Literature DB >> 16395399

Delving deeper into MALT lymphoma biology.

Francesco Bertoni1, Emanuele Zucca.   

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphomas can arise in a variety of extranodal sites. Interestingly, at least 3 different, apparently site-specific, chromosomal translocations, all affecting the NF-kappaB pathway, have been implicated in the development and progression of MALT lymphoma. The most common is the translocation t(11;18)(q21;q21), which results in a fusion of the cIAP2 region on chromosome 11q21 with the MALT1 gene on chromosome 18q21 and is present in more than one-third of cases. The frequency of this translocation is site-related: common in the gastrointestinal tract and lung, rare in conjunctiva and orbit, and almost absent in salivary glands, thyroid, liver, and skin. In this issue of the JCI, Hu et al. add to our understanding of the molecular consequences of this translocation, showing that its fusion product, cIAP2-MALT1, may concomitantly contribute to lymphomagenesis both as a tumor suppressor gene and as an oncogene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395399      PMCID: PMC1323273          DOI: 10.1172/JCI27476

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.

Authors:  P C Lucas; M Yonezumi; N Inohara; L M McAllister-Lucas; M E Abazeed; F F Chen; S Yamaoka; M Seto; G Nunez
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

2.  Mechanisms of apoptosis.

Authors:  J C Reed
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

3.  BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.

Authors:  H Ye; A Dogan; L Karran; T G Willis; L Chen; I Wlodarska; M J Dyer; P G Isaacson; M Q Du
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 4.  Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.

Authors:  Daphne de Jong
Journal:  J Clin Oncol       Date:  2005-09-10       Impact factor: 44.544

Review 5.  IAPs, RINGs and ubiquitylation.

Authors:  David L Vaux; John Silke
Journal:  Nat Rev Mol Cell Biol       Date:  2005-04       Impact factor: 94.444

6.  T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma.

Authors:  Berthold Streubel; Andrea Lamprecht; Judith Dierlamm; Lorenzo Cerroni; Manfred Stolte; German Ott; Markus Raderer; Andreas Chott
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

7.  MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.

Authors:  Hongtao Ye; Liping Gong; Hongxiang Liu; Rifat A Hamoudi; Sima Shirali; Liza Ho; Andreas Chott; Berthold Streubel; Reiner Siebert; Stefan Gesk; Jose I Martin-Subero; John A Radford; Sankar Banerjee; Andrew G Nicholson; Renzo Ranaldi; Ellen D Remstein; Zifen Gao; Jie Zheng; Peter G Isaacson; Ahmet Dogan; Ming-Qing Du
Journal:  J Pathol       Date:  2005-02       Impact factor: 7.996

8.  MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.

Authors:  Liza Ho; R Eric Davis; Béatrice Conne; Richard Chappuis; Margaret Berczy; Paulette Mhawech; Louis M Staudt; Juerg Schwaller
Journal:  Blood       Date:  2004-12-14       Impact factor: 22.113

9.  Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity.

Authors:  Honglin Zhou; Ming-Qing Du; Vishva M Dixit
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

10.  T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma.

Authors:  B Streubel; U Vinatzer; A Lamprecht; M Raderer; A Chott
Journal:  Leukemia       Date:  2005-04       Impact factor: 11.528

View more
  18 in total

1.  The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

Authors:  Urban Novak; Andrea Rinaldi; Ivo Kwee; Subhadra V Nandula; Paola M V Rancoita; Mara Compagno; Michaela Cerri; Davide Rossi; Vundavalli V Murty; Emanuele Zucca; Gianluca Gaidano; Riccardo Dalla-Favera; Laura Pasqualucci; Govind Bhagat; Francesco Bertoni
Journal:  Blood       Date:  2009-03-03       Impact factor: 22.113

2.  Genomic profiles of MALT lymphomas: variability across anatomical sites.

Authors:  Ivo Kwee; Paola M V Rancoita; Andrea Rinaldi; Andrés J M Ferreri; Govind Bhagat; Randy D Gascoyne; Vincenzo Canzonieri; Gianluca Gaidano; Claudio Doglioni; Emanuele Zucca; Maurilio Ponzoni; Francesco Bertoni
Journal:  Haematologica       Date:  2011-04-01       Impact factor: 9.941

3.  A structurally distinct human mycoplasma protein that generically blocks antigen-antibody union.

Authors:  Rajesh K Grover; Xueyong Zhu; Travis Nieusma; Teresa Jones; Isabel Boreo; Amanda S MacLeod; Adam Mark; Sherry Niessen; Helen J Kim; Leopold Kong; Nacyra Assad-Garcia; Keehwan Kwon; Marta Chesi; Vaughn V Smider; Daniel R Salomon; Diane F Jelinek; Robert A Kyle; Richard B Pyles; John I Glass; Andrew B Ward; Ian A Wilson; Richard A Lerner
Journal:  Science       Date:  2014-02-07       Impact factor: 47.728

4.  Ectopic B-cell clusters that infiltrate transplanted human kidneys are clonal.

Authors:  Julong Cheng; Ali Torkamani; Rajesh K Grover; Teresa M Jones; Diana I Ruiz; Nicholas J Schork; Michael M Quigley; F Wesley Hall; Daniel R Salomon; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

5.  The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys.

Authors:  Rajesh K Grover; Julong Cheng; Yingjie Peng; Teresa M Jones; Diana I Ruiz; Richard J Ulevitch; John I Glass; Edward A Dennis; Daniel R Salomon; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-06       Impact factor: 11.205

Review 6.  Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives.

Authors:  Dominic Kaddu-Mulindwa; Lorenz Thurner; Konstantinos Christofyllakis; Moritz Bewarder; Igor Age Kos
Journal:  Cancers (Basel)       Date:  2022-06-19       Impact factor: 6.575

Review 7.  Clinical aspects of malt lymphomas.

Authors:  Christina Kalpadakis; Gerassimos A Pangalis; Theodoros P Vassilakopoulos; Stavroula Kyriakaki; Xanthi Yiakoumis; Sotirios Sachanas; Maria Moschogiannis; Pantelis Tsirkinidis; Penelope Korkolopoulou; Helen A Papadaki; Maria K Angelopoulou
Journal:  Curr Hematol Malig Rep       Date:  2014-09       Impact factor: 3.952

8.  The clinical potential of circulating immune cell counts in primary gastric lymphoma.

Authors:  Ayman Haimour; Osama Abu-Shawer; Mohammad Abu-Shawer; Ali Al-Taji; Tamer Altamimi; Razan Mansour; Justin Z Amarin; Hala Sultan; Maysa Al-Hussaini
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 9.  Gastric MALT lymphoma: old and new insights.

Authors:  Angelo Zullo; Cesare Hassan; Lorenzo Ridola; Alessandro Repici; Raffaele Manta; Alessandro Andriani
Journal:  Ann Gastroenterol       Date:  2014

Review 10.  The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives.

Authors:  Lina Elsalem; Ahmad A Jum'ah; Mahmoud A Alfaqih; Osama Aloudat
Journal:  Clin Exp Gastroenterol       Date:  2020-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.